Tag: ZNc3
Zentalis Pharmaceuticals Announces Promising Initial Data Presented in a Late-Breaking Session...
ZN-c3 demonstrated single agent activity, generating Exceptional Responses in a range of heavily pre-treated solid tumors ZN-c3 was safe and well-tolerated ...